Fibrinogen Bethesda: a congenital dysfibrinogenemia with delayed fibrinopeptide release.
about
"Fibrinogen Tokyo II". An abnormal fibrinogen with an impaired polymerization site on the aligned DD domain of fibrin moleculesCoupling of the adhesive receptor CD11b/CD18 to functional enhancement of effector macrophage tissue factor response.Fibrinogen Philadelphia. A hereditary hypodysfibrinogenemia characterized by fibrinogen hypercatabolism.Fibrinogen Cleveland II. An abnormal fibrinogen with defective release of fibrinopeptide A.Three cases of congenital dysfibrinogenemia in unrelated Chinese families: heterozygous missense mutation in fibrinogen alpha chain Argl6His.Dysfibrinogenaemia and liver cell growth.Dysfibrinogenemia associated with liver diseaseFibrinogen Baltimore II: congenital hypodysfibrinogenemia with delayed release of fibrinopeptide B and decreased rate of fibrinogen synthesis.A gamma methionine-310 to threonine substitution and consequent N-glycosylation at gamma asparagine-308 identified in a congenital dysfibrinogenemia associated with posttraumatic bleeding, fibrinogen Asahi.Inhibition of fibrin monomer polymerisation by myeloma immunoglobulin.Selected topics on blood coagulation.Sulfated sericin is a novel anticoagulant influencing the blood coagulation cascade.A novel mutation in the fibrinogen Aα chain (Gly13Arg, fibrinogen Nanning) causes congenital dysfibrinogenemia associated with defective peptide A release.Fibrinogen Seoul (FGG Ala341Asp): a novel mutation associated with hypodysfibrinogenemia.
P2860
Q33822352-C5B552DD-6467-4FC5-A9AB-80741595CA13Q34174791-7BB6B042-AAF7-461F-BB49-3F149775B131Q34462314-1CB40860-6785-4A64-87C9-CB1DEC3C92A4Q34517341-F62E7C1F-6D7E-4B58-A68B-A21EC604D83DQ36148140-ACEADCD1-1D35-44D9-AC2E-90F5BBB093BEQ36618275-3590D1D7-8EC9-4F95-8FB1-767025EE6D62Q37045458-7B5C7812-0E92-40A5-837B-60DF6529B5EAQ37509831-55BF97A6-A108-4AFB-B475-9937FDD302E4Q38344795-298905D7-3EA1-433C-A727-B80C9D80A4D6Q39630389-22FBDAAF-86D9-436E-A891-60E8524AF2B6Q39948297-5B1DBCDA-89B3-4EF8-B126-7D306BD4C2CDQ42025813-671E5B98-DC3F-4CFD-BF64-2E23AF1CFA2DQ47922026-5DF533CF-60F4-46B6-B5EF-52E78901EAA5Q53589112-1AC3F00A-2CE2-4E39-ABAE-24F15411EC52
P2860
Fibrinogen Bethesda: a congenital dysfibrinogenemia with delayed fibrinopeptide release.
description
1971 nî lūn-bûn
@nan
1971 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1971 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1971年の論文
@ja
1971年論文
@yue
1971年論文
@zh-hant
1971年論文
@zh-hk
1971年論文
@zh-mo
1971年論文
@zh-tw
1971年论文
@wuu
name
Fibrinogen Bethesda: a congenital dysfibrinogenemia with delayed fibrinopeptide release.
@ast
Fibrinogen Bethesda: a congenital dysfibrinogenemia with delayed fibrinopeptide release.
@en
Fibrinogen Bethesda: a congenital dysfibrinogenemia with delayed fibrinopeptide release.
@nl
type
label
Fibrinogen Bethesda: a congenital dysfibrinogenemia with delayed fibrinopeptide release.
@ast
Fibrinogen Bethesda: a congenital dysfibrinogenemia with delayed fibrinopeptide release.
@en
Fibrinogen Bethesda: a congenital dysfibrinogenemia with delayed fibrinopeptide release.
@nl
prefLabel
Fibrinogen Bethesda: a congenital dysfibrinogenemia with delayed fibrinopeptide release.
@ast
Fibrinogen Bethesda: a congenital dysfibrinogenemia with delayed fibrinopeptide release.
@en
Fibrinogen Bethesda: a congenital dysfibrinogenemia with delayed fibrinopeptide release.
@nl
P2093
P2860
P356
P1476
Fibrinogen Bethesda: a congenital dysfibrinogenemia with delayed fibrinopeptide release.
@en
P2093
Finlayson JS
Givelber HM
Gralnick HR
Shainoff JR
P2860
P304
P356
10.1172/JCI106673
P407
P577
1971-09-01T00:00:00Z